Supportive Management and Interventions for Respiratory Failure Due to SARS-CoV-2

Area of Science:

• Critical Care Medicine
• Infectious Diseases
• Pulmonology

Background:

• Severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection presents a spectrum of illness, from asymptomatic cases to severe respiratory failure.
• Respiratory failure, including acute respiratory distress syndrome (ARDS), necessitates intubation and mechanical ventilation in critically ill patients.
• Effective patient triaging is crucial for infection control, resource allocation, and optimal patient outcomes.

Purpose of the Study:

• To review the distinct phenotypes of respiratory failure observed in SARS-CoV-2 infection.
• To outline current approaches to mechanical ventilation for patients with SARS-CoV-2-induced respiratory compromise.
• To discuss strategies for managing refractory hypoxemia in the context of SARS-CoV-2.

Main Methods:

• Literature review of clinical studies and guidelines related to SARS-CoV-2 respiratory failure.
• Analysis of patient data to identify distinct respiratory failure phenotypes.
• Synthesis of evidence regarding mechanical ventilation and hypoxemia management.

Main Results:

• Two primary phenotypes of respiratory failure in SARS-CoV-2 infection have been identified.
• Mechanical ventilation is a key supportive therapy for respiratory failure, requiring careful management.
• Refractory hypoxemia presents a significant challenge, necessitating advanced management strategies.

Conclusions:

• Understanding SARS-CoV-2 respiratory failure phenotypes guides clinical decision-making.
• Optimized mechanical ventilation strategies are essential for improving outcomes in severe cases.
• Effective management of refractory hypoxemia is critical for reducing mortality in SARS-CoV-2 patients.